# Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase

> **NCT01865695** · PHASE4 · TERMINATED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 2 (actual)

## Conditions studied

- Patients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks)
- Patients With Pancreatic Exocrine Insufficiency

## Interventions

- **DRUG:** Creon
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01865695
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of participant enrolment
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865695, "Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01865695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*